Rheumatoid arthritis exacerbation by G-CSF treatment for bucillamine-induced agranulocytosis.
Nakashima
H
H
Kawabe
K
K
Ohtsuka
T
T
Hayashida
K
K
Horiuchi
T
T
Nagasawa
K
K
Niho
Y
Y
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced / Q000188:drug therapy*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000139:chemically induced* / Q000188:drug therapy; D003545:Cysteine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D006801:Humans
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016179:Granulocyte Colony-Stimulating Factor; D003545:Cysteine; C026535:bucillamine